Chromocure, Inc./ US1711271031 /
09/05/2024 15:30:00 | Diferencia - | Volumen | Bid- | Ask- | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
0.0000USD | - | 500,000 Volumen de negocios: .5000 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 0.0000 | 0.0000 |
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
GlobeNewswire
02/06
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
02/06
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1...
GlobeNewswire
02/06
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT...
GlobeNewswire
02/06
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Sub...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página